Apogee Therapeutics Inc (APGE) PT Raised to $135 at Truist Securities
August 13, 2026 7:09 AM
Truist Securities analyst Danielle Brill raised the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $135.00 (from $81.00) while maintaining a Hold rating.
